Relieving Lung disease in COVID-19 Patients with Aerosols that Carry Viral Genes Inhibitors
Relieving Lung disease in COVID-19 Patients with Aerosols that Carry Viral Genes Inhibitors Project ID : 47-2020-10887
Innovative Products and Technologies
Relieving Lung disease in COVID-19 Patients with Aerosols that Carry Viral Genes Inhibitors
Project ID : 47-2020-10887
Project manager
Mel Larrosa
VP Business Development Healthcare
Project researchers
Itamar Willner
HUJI, Faculty of Science
The Institute of Chemistry
Moshe Kotler
HUJI, School of Medicine - IMRIC
Immunology and Cancer Research
Eli Pikarsky
HUJI, School of Medicine - IMRIC
Immunology and Cancer Research
Yissum - Research Development Company of the Hebrew University
Technology Transfer Office from Israel
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Founded in 1964 to protect and commercialize the Hebrew University’s intellectual property. Ranked among the top technology transfer companies, Yissum has registered over 8,900 patents covering 2,500 inventions; has licensed out 800 technologies and has spun-off 90 companies. Products that are based on Hebrew University technologies and were commercialized by Yissum generate today over $2 Billion in annual sales.
Create your free account to connect with Yissum - Research Development Company of the Hebrew University and thousands of other innovative organizations and professionals worldwide
Send a request for information
to Yissum - Research Development Company of the Hebrew University
Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.
Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support